Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Bloomberg’s Caroline Hyde and Ed Ludlow ...
Tom Lee, Fundstrat, joins 'Closing Bell'...
CNBCs Eamon Javers joins 'Closing Bell O...
Michael Froman, fmr. U.S. Trade represen...
CNBC's Pippa Stevens joins 'Closing Bell...
Donald Trump’s attack on Iran will deliv...
CNBC's Eamon Javers reports on news from...
Megan O'Sullivan, Harvard Belfer Center,...
Should you pay off your student loan? Th...
Legora CEO Max Junestrand says the legal...
A Christian hotel owner opened her doors...